Pediatrix Medical Group, Inc. announced that its board of directors has elected James D. Swift, M.D., the Company's chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.1 USD | +4.87% | -0.70% | -23.66% |
Jun. 07 | Deutsche Bank Upgrades Pediatrix Medical Group to Hold From Sell, $8 Price Target | MT |
May. 07 | Transcript : Pediatrix Medical Group, Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.66% | 588M | |
+25.91% | 89.26B | |
-24.02% | 75.31B | |
+5.42% | 27.41B | |
+6.77% | 18.36B | |
-13.61% | 16.55B | |
+0.69% | 15.42B | |
+79.76% | 13.83B | |
-25.09% | 12.64B | |
+22.83% | 12.53B |
- Stock Market
- Equities
- MD Stock
- News Pediatrix Medical Group, Inc.
- Pediatrix Medical Group, Inc. Announces Board Changes